TG Therapeutics posts late-stage trial win for Briumvi single infusion regimen
TG Therapeutics, Inc. · PHARMACEUTICAL PREPARATIONS · Now $37.94
-5.0% in 1d after detection
Post-detection moves
1h
-1.9%
1d
-5.0%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS